Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by ssdasmmon Feb 03, 2021 1:45pm
80 Views
Post# 32459942

RE:MANY

RE:MANYIn my opinion only, I think the question will be asked and some guidance will be given.  In a earlier update Cameron also menitoned that  they have been approached by other customers to duplicate or even double what there are doing for the Ontario Government, so that might be mentioned again.  The update could include how they achieved a record Q1, the acceleration of QAP sales and a update on VTM, should be vey interesting.
<< Previous
Bullboard Posts
Next >>